La FDA statunitense ha approvato la formulazione orale di semaglutide 25 mg di Novo Nordisk, commercializzata come Wegovy, indicata per la gestione cronica del peso
Looking ahead, NASH trials ought to incorporate a thorough evaluation of the systemic drivers, modifiers, and manifestations of the disease
Comparing the different versions of GLP-1s, semaglutide is more effective at supporting weight loss than liraglutide
On the other hand, compounded semaglutide may contain additional ingredients such as vitamin B-12, vitamin B-6, L-carnitine, and others
Adrenergic/Serotonergic Agents Sibutramine (Meridia) is an adrenergic/serotonergic agent approved by the FDA in 1997 for use in the management of obesity